CD274 and neoplasm: These MDP fragments activate nucleotide-binding oligomerization domain 2-dependent signaling pathways, induce the expression of pro-inflammatory genes, and promote cytotoxic T-lymphocyte (CTL) activation within the tumor microenvironment, consequently resulting in the enhancement of anti-PD-L1 antitumor efficacy (65).